MedTrace Logo

Spinal Cord Neuromodulation for Spinal Cord Injury

NCT02313194 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-02-13

No results posted yet for this study

Summary

This study is designed to assess the strategy of using spinal cord stimulation to improve the ability to move in spinal cord injured humans.

Conditions

  • Cervical Spinal Cord Injury
  • Tetraparesis
  • Tetraplegia

Interventions

DEVICE

Epidural Stimulation

Determine if epidural stimulation can improve motor function

DRUG

Buspirone

Determine if the pharmacological agent in combination with the stimulator can improve motor function.

Sponsors & Collaborators

Principal Investigators

  • Daniel C Lu, MD PhD · University of California, Los Angeles

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2026-06-30
Completion
2026-12-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02313194 on ClinicalTrials.gov